FOCUS Equilab, Jakarta

FOCUS has expanded its operations through an alliance with Equilab in Jakarta, Indonesia to offer high quality bioequivalence studies at low costs. The Jakarta area offers access to a population of 9 Mio. people.

We offer:

• Generic Bioequivalence Studies according to ICH-standard (incl. Bioanalytics and PK)
• Bioavailability and PK of modified release formulations
• Pilot PK studies for:
• initial PK profiling of sampling times and half life
• screening of new dosage forms in man
• Food effect studies
• Intra-individual pharmacogenomic comparison studies